Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction
Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
As an adjunct to fibrinolysis in ST-elevation myocardial infarction, 7 days of enoxaparin was superior to 48 hours of unfractionated heparin. However, the enoxaparin regimen was associated with more episodes of bleeding. Considering both efficacy and safety together, this study found that the enoxaparin regimen had a net clinical benefit, as compar...
Alternative Titles
Full title
Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_csuc_recercat_oai_recercat_cat_2072_321619
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_csuc_recercat_oai_recercat_cat_2072_321619
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa060898
